Chemoinformaics analysis of LAURIFOLINE CHLORIDE
| Molecular Weight | 377.868 | nRot | 2 |
| Heavy Atom Molecular Weight | 353.676 | nRig | 20 |
| Exact Molecular Weight | 377.139 | nRing | 4 |
| Solubility: LogS | -0.14 | nHRing | 1 |
| Solubility: LogP | 0.175 | No. of Aliphatic Rings | 2 |
| Acid Count | 1 | No. of Aromatic Rings | 2 |
| Base Count | 1 | No. of Aliphatic Carbocycles Rings | 1 |
| Atoms Count | 50 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 6 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 24 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 20 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 1 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
| nHA | 4 | APOL | 55.891 |
| nHD | 2 | BPOL | 29.829 |
| QED | 0.824 |
| Synth | 3.522 |
| Natural Product Likeliness | 2.16 |
| NR-PPAR-gamma | 0.022 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.001 |
| Pgp-sub | 0.987 |
| HIA | 0.967 |
| CACO-2 | -5.78 |
| MDCK | 0.00000386 |
| BBB | 0.108 |
| PPB | 0.361042 |
| VDSS | 2.092 |
| FU | 0.440606 |
| CYP1A2-inh | 0.108 |
| CYP1A2-sub | 0.958 |
| CYP2c19-inh | 0.015 |
| CYP2c19-sub | 0.095 |
| CYP2c9-inh | 0.001 |
| CYP2c9-sub | 0.39 |
| CYP2d6-inh | 0.017 |
| CYP2d6-sub | 0.93 |
| CYP3a4-inh | 0.031 |
| CYP3a4-sub | 0.517 |
| CL | 3.6 |
| T12 | 0.912 |
| hERG | 0.094 |
| Ames | 0.107 |
| ROA | 0.133 |
| SkinSen | 0.155 |
| Carcinogencity | 0.013 |
| EI | 0.012 |
| Respiratory | 0.457 |
| NR-Aromatase | 0.014 |
| Antiviral | Yes |
| Prediction | 0.675335 |